Kenvue Inc. Stock

Equities

KVUE

US49177J1025

Personal Products

Market Closed - Nyse 16:00:02 2024-05-23 EDT 5-day change 1st Jan Change
19.44 USD -2.21% Intraday chart for Kenvue Inc. -5.36% -9.71%
Sales 2024 * 15.69B 21.54B Sales 2025 * 16.23B 22.28B Capitalization 38.07B 52.25B
Net income 2024 * 1.71B 2.35B Net income 2025 * 2.08B 2.85B EV / Sales 2024 * 2.87 x
Net Debt 2024 * 6.93B 9.51B Net Debt 2025 * 6.41B 8.8B EV / Sales 2025 * 2.74 x
P/E ratio 2024 *
21.9 x
P/E ratio 2025 *
18.3 x
Employees 22,000
Yield 2024 *
3.85%
Yield 2025 *
4.14%
Free-Float 99.72%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.21%
1 week-5.36%
Current month+3.29%
1 month-0.72%
3 months+1.30%
6 months-2.99%
Current year-9.71%
More quotes
1 week
19.38
Extreme 19.38
20.74
1 month
18.64
Extreme 18.64
20.95
Current year
18.61
Extreme 18.61
22.04
1 year
17.82
Extreme 17.82
26.74
3 years
17.82
Extreme 17.82
27.80
5 years
17.82
Extreme 17.82
27.80
10 years
17.82
Extreme 17.82
27.80
More quotes
Date Price Change Volume
24-05-23 19.44 -2.21% 15,932,704
24-05-22 19.88 -0.45% 15,202,580
24-05-21 19.97 +0.35% 27,778,988
24-05-20 19.9 -2.78% 24,636,833
24-05-17 20.47 -0.63% 31,071,005

Delayed Quote Nyse, May 23, 2024 at 04:00 pm

More quotes
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. The business is organized around 3 product families: - health products: for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - body care products: hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.); - other: notably oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.). Product marketing is assured through direct sales, distributors and the Internet.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
19.88 USD
Average target price
22.8 USD
Spread / Average Target
+14.66%
Consensus